Codes / ICD10CM / T50.995

T50.995 Adverse effect of other drugs, medicaments and biological substances

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of other drugs, medicaments and biological substances (ICD-10 Code: T50.995)

Summary

This condition describes harmful effects resulting from exposure to drugs, medicaments, or biological substances categorized as "other" (not specified elsewhere in the ICD-10-CM classification). It includes adverse reactions, toxic effects, or unintended consequences of these substances, with the clinical presentation and management depending on the specific agent involved and the nature of the exposure. The term "other" indicates the substance is not classified under more detailed codes.

Causes

Exposure to other drugs or biological substances can occur through therapeutic use (e.g., prescribed medications), accidental ingestion, or adverse reactions. The cause may be unknown or unspecified, particularly when the substance is not covered by more detailed codes or when the event is unreported.

Risk Factors

  • Concurrent use of multiple medications increasing interaction risk
  • History of substance misuse or self-harm behaviors
  • Lack of supervision in medication administration (e.g., in vulnerable populations)
  • Underlying conditions requiring drug therapy
  • Polypharmacy (use of multiple medications)

Symptoms

Symptoms can vary widely based on the substances involved but may include:

  • Gastrointestinal distress (nausea, vomiting, abdominal pain)
  • Neurological effects (dizziness, confusion, seizures)
  • Cardiovascular instability (hypotension, arrhythmias)
  • Respiratory depression or distress
  • Skin reactions (rash, itching, swelling)
  • Metabolic disturbances (e.g., electrolyte imbalances)

Diagnosis

Diagnosis involves a thorough clinical evaluation, including a detailed history of substance exposure, medication use, and symptom onset. Laboratory tests (e.g., toxicology screens, blood work) may be used to identify the specific agent or assess organ function. Imaging or other diagnostic tools may be employed if organ damage is suspected.

Treatment Options

Treatment focuses on managing symptoms, supporting organ function, and removing the offending substance (if possible). This may include activated charcoal, antidotes (if available), intravenous fluids, or supportive care (e.g., respiratory support). Discontinuation of the causative agent is often necessary.

Prognosis and Follow-Up

Prognosis depends on the substance involved, the extent of exposure, and the timeliness of treatment. Most adverse effects resolve with appropriate management, but severe cases may lead to long-term complications. Follow-up care may involve monitoring for recurrence, adjusting medications, or addressing underlying risk factors.

Complications

Potential complications include organ damage (e.g., liver or kidney failure), persistent neurological deficits, or life-threatening reactions (e.g., anaphylaxis). Delayed treatment or severe exposure increases the risk of adverse outcomes.

Lifestyle & Prevention

  • Store medications securely to prevent accidental access.
  • Follow dosing instructions carefully and avoid self-adjusting medications.
  • Inform healthcare providers of all substances (including over-the-counter drugs and supplements) being used.
  • Use medication organizers or reminders to avoid dosing errors.
  • Seek guidance on potential drug interactions when starting new therapies.

When to Seek Professional Help

Seek immediate medical attention if symptoms of an adverse reaction occur, such as difficulty breathing, severe pain, confusion, or signs of an allergic reaction (e.g., swelling, rash). Contact a healthcare provider for persistent or worsening symptoms after substance exposure.

Tips for Medical Coders

Document the specific drug, medicament, or biological substance involved, if known, to support coding accuracy. Include details about the nature of the adverse effect (e.g., allergic reaction, toxicity) and the clinical context (e.g., therapeutic use, accidental exposure). Ensure the code aligns with the documented event and substance classification.

Book a walkthrough

T50.995 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.